Biomarin Pharmaceutical Inc (BMRN) earnings · P/E 147, rev $3.22B
These earnings events as JSON? API free 100/dayBiomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
This BMRN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BMRN revenue for 2025-12-31 was $3.22B. Net income was $348.9M. Revenue was up 12.9% from 2024-12-31 to 2025-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 147.5.
When the next BMRN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 12.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BMRN research stays on the stock page; the tape stays on the quote page.
BMRN earnings FAQ
What are BMRN's latest revenue and net income?
Latest cached Biomarin Pharmaceutical Inc (BMRN) revenue for Dec 31, 2025 was $3.22B. Net income was $348.9M. Statements: https://lician.com/financials/bmrn
What is BMRN's latest diluted EPS?
Latest cached Biomarin Pharmaceutical Inc (BMRN) diluted EPS for Dec 31, 2025 was $1.80.
What period does the latest BMRN earnings print cover?
The latest cached Biomarin Pharmaceutical Inc (BMRN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BMRN revenue change from the prior cached period?
Cached Biomarin Pharmaceutical Inc (BMRN) revenue was up 12.9% from $2.85B (Dec 31, 2024) to $3.22B (Dec 31, 2025). Statements: https://lician.com/financials/bmrn
What is BMRN's P/E ratio?
Biomarin Pharmaceutical Inc (BMRN) trailing P/E is 147.5 on the latest cached fundamentals snapshot.
Where are BMRN earnings listed?
Cached earnings facts for Biomarin Pharmaceutical Inc (BMRN) are listed at https://lician.com/earnings/bmrn. Statements: https://lician.com/financials/bmrn
Not investment advice.